PACS: Pediatric Analgesia after Cardiac SUrgery

DOI

This is a a multi-center randomized controlled trial in children aged 0-36 months after cardiac surgery..Morphine is worldwide the analgesic of first choice after cardiac surgery in children. Morphine hasunwanted hemodynamic and respiratory side effects. Therefore, post–cardiac surgery patients may potentiallybenefit from a non-opioid drug for pain relief.The aim of the study is to test the hypothesis that intermittent IV paracetamol administration in children after cardiac surgery will result in a reduction of at least 30% of the cumulative morphine requirement in the first 48 hours.This is a prospective, multi-center, randomized controlled trial at four level-3 pediatric intensive care units(ICUs) in the Netherlands and Belgium. Children who are 0–36 months old are randomly assigned toreceive either intermittent IV paracetamol or continuous IV morphine up to 48 h post-operatively. Morphinewill be available as rescue medication for both groups. Validated pain and sedation assessment tools will beused to monitor patients. The sample size (n = 208, 104 per arm) was calculated in order to detect a 30%reduction in morphine dose; two-sided significance level was 5% and power was 95%.

Date Submitted: 2023-04-06

Identifier
DOI https://doi.org/10.17026/dans-zkf-b9vg
Metadata Access https://lifesciences.datastations.nl/oai?verb=GetRecord&metadataPrefix=oai_datacite&identifier=doi:10.17026/dans-zkf-b9vg
Provenance
Creator E.D. Wildschut ORCID logo
Publisher DANS Data Station Life Sciences
Contributor E D Wildschut
Publication Year 2024
Rights DANS Licence; info:eu-repo/semantics/restrictedAccess; https://doi.org/10.17026/fp39-0x58
OpenAccess false
Contact E D Wildschut (ErasmusMC Sophia Kinderziekenhuis)
Representation
Resource Type Dataset
Format application/zip; text/plain
Size 16178; 144
Version 1.0
Discipline Anaesthesiology; Life Sciences; Medicine; Medicine and Health; Pharmacology